You are here
October 24, 2016
The Zika epidemic is a growing and evolving global health emergency that has already spread to more than 45 countries, including U.S. territories and the continental U.S.1 Healthcare professionals are working rapidly to identify solutions for those impacted, and while the Centers for Disease Control and Prevention (CDC) is tracking the virus, it is not able to predict how much Zika will spread in the continental U.S.
“A challenge like Zika requires every organization to bring forward their resources and expertise to manage health risks that exist for people in affected areas of the country,” said Sally Susman, Executive Vice President, Corporate Affairs, Pfizer Inc. “We welcome the opportunity to partner with the CDC Foundation and healthcare professionals to address today’s health needs while work continues to identify longer-term solutions.”
To that end, through the Pfizer Foundation*, Pfizer has donated funding to support surveillance, prevention and educational efforts surrounding Zika in the continental U.S., Puerto Rico and Latin America.
Spread primarily through the bite of an infected Aedes mosquito, Zika can be passed from a pregnant woman to her unborn child.2 Infection during pregnancy can cause microcephaly, a birth defect characterized by an unusually small head, often accompanied by brain damage.2 Zika has also been linked to Guillain-Barré syndrome, a rare disorder that can cause muscle weakness and sometimes paralysis.2